ReviewEuropean respiratory review : an official journal of the European Respiratory Society2020
Developments in lung transplantation over the past decade.
Review in European respiratory review : an official journal of the European Respiratory Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
75 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- Utility and safety of airway stenting in airway stenosis after lung transplant: A systematic review.Frontiers in medicine · 2023Pooled it
- Global strategies to improve equitable access to heart and lung transplantation- ISHLT Consortium Report.JHLT open · 2026Review
- Research advances in consistency and variability inJournal of thoracic disease · 2026Review
- Predicting Acute Kidney Injury After Lung Transplantation: Development and Internal Validation of Perioperative Prediction Models.Clinical transplantation · 2026Article
- Observational
- Next-Generation In Vitro Pulmonary Platforms for Respiratory Disease Modelling and Therapeutic Development: Current Advances and Future Prospects.Medicina (Kaunas, Lithuania) · 2026Review
- Early post-transplant recipient tissue injury predicts allograft function, rejection and survival in lung transplant recipients: evidence from cell-free DNA.The European respiratory journal · 2026Article
- Relationship between nutrition support and clinical outcomes in post-lung transplant patients in intensive care unit settings: A retrospective study.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026Article
- Risk Factors for Acute Rejection in Pediatric Lung Transplantation and Its Impact on Graft Failure.Pediatric pulmonology · 2026Article
- Experience with isavuconazole in lung transplant recipients withJHLT open · 2026Article
- Article
- EBV-Negative Post-Lung Transplant Lymphoma Diagnosed via Paracentesis: A Case Report and Literature Review.Case reports in transplantation · 2026Article
- Association of prolonged ECMO bridging and perioperative factors with dysphagia and survival after lung transplantation.PloS one · 2026Article
- Association Between Three Lung Donor Scores and Lung Acceptance in DBD and DCD Donors.Transplant international : official journal of the European Society for Organ Transplantation · 2026Article
- Description of the Protocol Investigating Whether Remote Care Can Reduce Clinic Attendance in Lung Transplantation.Pulmonary therapy · 2025Article
- Identification of immune signatures associated with both SARS-CoV-2 infection and lung transplantation.Cell reports. Medicine · 2025Article
- Bilateral orthotopic lung transplantation for the patient with lung-limited invasive mucinous adenocarcinoma: a case-based literature review.The oncologist · 2025Review
- Association of Community Distress With Lung Transplant Waitlist Acceptance.Clinical transplantation · 2025Article
- Impact of Preoperative Opioid Use in Lung Transplant Recipients: A Retrospective Study.Cureus · 2025Article
15 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With an improved median survival of 6.2 years, lung transplantation has become an increasingly acceptable treatment option for end-stage lung disease. Besides survival benefit, improvement of quality of life is achieved in the vast majority of patients. Many developments have taken place in the field of lung transplantation over the past decade. Broadened indication criteria and bridging techniques for patients awaiting lung transplantation have led to increased waiting lists and changes in allocation schemes worldwide. Moreover, the use of previously unacceptable donor lungs for lung transplantation has increased, with donations from donors after cardiac death, donors with increasing age and donors with positive smoking status extending the donor pool substantially. Use of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.